Study guide

1.2 Dynamic Antepartum & Intrapartum Risk Assessment

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

1.2 Dynamic Antepartum & Intrapartum Risk Assessment

Key Takeaways Explain This Topic AI

Obstetric hemorrhage risk is dynamic and must be re-stratified at admission, during labor progression, and immediately postpartum; changes such as chorioamnionitis, prolonged oxytocin augmentation, or operative delivery automatically escalate patients to higher risk categories.

Pharmacologic cervical ripening agents, including misoprostol (PGE1) and dinoprostone (PGE2), are strictly contraindicated in patients with a scarred uterus due to high rates of catastrophic uterine rupture; mechanical dilation with a Foley balloon is the only evidence-based ripening method indicated for TOLAC.

Prolonged oxytocin exposure causes oxytocin receptor downregulation and desensitization within 4 to 6 hours, rendering the myometrium refractory to endogenous and exogenous oxytocin and significantly increasing the risk of severe postpartum uterine atony.

Uterine tachysystole (>5 contractions in 10 minutes averaged over 30 minutes) associated with Category II or III fetal heart rate tracings requires immediate discontinuation of oxytocin, maternal lateral repositioning, IV fluid bolus, and subcutaneous administration of 0.25 mg terbutaline if decelerations persist.

The Maternal Fetal Triage Index (MFTI) provides a validated 5-level acuity framework ensuring that Priority 1 (Stat/Critical) patients receive immediate continuous bedside physician care and Priority 2 (Urgent) patients are evaluated within 15 minutes.

Last updated: August 2026

Dynamic Antepartum & Intrapartum Risk Assessment

Obstetric risk is not a static baseline assigned at the initial prenatal visit. Maternal-fetal physiology continuously evolves throughout labor and delivery. A patient who presents at low risk can rapidly transition to high risk following the development of intrapartum fever, protracted labor arrest, uterine tachysystole, or placental separation. Systematic, continuous dynamic assessment is essential for preventing peripartum catastrophes.

1. CMQCC / ACOG Dynamic Obstetric Hemorrhage Risk Stratification

Postpartum hemorrhage (PPH) remains a leading cause of preventable severe maternal morbidity. The California Maternal Quality Care Collaborative (CMQCC) and ACOG establish that every parturient must be risk-stratified for hemorrhage on admission, reassessed continuously during labor, and re-evaluated immediately postpartum . +---------------------------------------------------------------------------------------------------+

  • | CMQCC / ACOG OBSTETRIC HEMORRHAGE RISK MATRIX |
  • | |
  • | LOW RISK (Type and Screen / Hold): |
  • | • Singleton pregnancy |
  • | • <=4 prior vaginal deliveries |
  • | • Unscarred uterus (no prior cesareans or transmural uterine surgeries) |
  • | • Absence of known bleeding disorders or coagulopathies |
  • | |
  • | MEDIUM RISK (Type and Screen Active on Admission): |
  • | • Prior cesarean delivery or transmural uterine surgery |
  • | • Multiple gestation (twins, triplets) |
  • | • >4 prior vaginal deliveries (grand multiparity) |
  • | • Chorioamnionitis / intra-amniotic infection |
  • | • History of prior postpartum hemorrhage |
  • | • Large uterine leiomyomas (>5 cm or multiple) |
  • | • Morbid obesity (BMI >35–40 kg/m²) |
  • | • Polyhydramnios (AFI >24 cm or maximum vertical pocket >8 cm) |
  • | • Estimated fetal weight >4,000–4,500 g (suspected macrosomia) |
  • | |
  • | HIGH RISK (Type and Crossmatch 2–4 Units PRBCs on Admission; Notify Anesthesia/Surgical Team): |
  • | • Placenta previa or low-lying placenta |
  • | • Suspected or confirmed Placenta Accreta Spectrum (PAS; accreta, increta, percreta) |
  • | • Active vaginal bleeding on admission (> normal bloody show) |
  • | • Known maternal coagulopathy or thrombocytopenia (platelets <100,000/mcL) |
  • | • >=2 prior cesarean deliveries with current anterior low placenta |
  • | • Severe anemia on admission (Hematocrit <30% or Hemoglobin <10 g/dL) with additional risk factor|
  • +---------------------------------------------------------------------------------------------------+
  • The Principle of Dynamic Re-Stratification

A low-risk patient must be upgraded to Medium Risk or High Risk immediately upon the emergence of intrapartum risk factors:

Augmentation with oxytocin for >4 to 6 hours.

Development of intrapartum chorioamnionitis (triple I / intrauterine inflammation or infection).

Active labor lasting >12 to 18 hours or prolonged second stage (>2 to 3 hours).

Administration of magnesium sulfate infusion for preeclampsia or neuroprotection.

Transition from spontaneous vaginal birth to vacuum-assisted, forceps-assisted, or emergency cesarean delivery.

2. Bishop Scoring & Safe Cervical Ripening in the Scarred Uterus

The Modified Bishop Score quantitatively assesses cervical readiness for induction of labor. A Bishop score of >=8 indicates a favorable cervix with induction success rates comparable to spontaneous labor. A score of <=6 indicates an unfavorable cervix requiring cervical ripening prior to oxytocin induction.

  • Bishop Parameter 0 Points 1 Point 2 Points 3 Points
  • Dilation (cm) Closed (0 cm) 1–2 cm 3–4 cm >=5 cm
  • Effacement (%) 0–30% 40–50% 60–70% >=80%
  • Fetal Station -3 -2 -1, 0 +1, +2, +3
  • Cervical Consistency Firm Medium Soft —
  • Cervical Position Posterior Midposition Anterior —
  • Cervical Ripening in the Scarred Uterus (TOLAC Safety)

In patients undergoing a Trial of Labor After Cesarean (TOLAC) or with a history of prior transmural uterine incision: +---------------------------------------------------------------------------------------------------+

  • | CRITICAL CONTRAINDICATION ALERT: PROSTAGLANDINS |
  • | |
  • | • Misoprostol (PGE1, Cytotec) and Dinoprostone (PGE2, Cervidil / Prepidil) are |
  • | STRICTLY CONTRAINDICATED for cervical ripening or labor induction in patients with a |
  • | prior cesarean delivery or prior transmural uterine scar. |
  • | • Clinical Rationale: Prostaglandin-induced hyperstimulation and collagen degradation in the |
  • | lower uterine segment dramatically increase the risk of catastrophic uterine rupture |
  • | (exceeding 2% to 5% with misoprostol vs 0.5% to 0.9% baseline). |
  • | • Method of Choice: MECHANICAL CERVICAL RIPENING with a transcervical Foley balloon catheter |
  • | (inflated with 30–60 mL sterile saline) or double-balloon catheter. Balloon ripening is |
  • | safe, does not increase uterine rupture rates, and mechanically promotes cervical effacement. |
  • +---------------------------------------------------------------------------------------------------+
  • 3. Oxytocin Receptor Desensitization & Tachysystole Protocol
  • Oxytocin Pharmacodynamics & Receptor Downregulation

Oxytocin is a cyclic nonapeptide with an elimination half-life of 10 to 15 minutes. Uterine myometrial sensitivity to oxytocin increases dramatically in late gestation due to a 300-fold upregulation of G-protein coupled oxytocin receptors.

However, continuous high-dose oxytocin infusions (>4 to 6 hours) trigger oxytocin receptor internalization, phosphorylation, and desensitization . Consequently, when oxytocin is infused for prolonged periods during labor, the myometrium becomes refractory to both endogenous and exogenous oxytocin. This phenomenon represents a primary pathophysiological mechanism of refractory postpartum uterine atony , necessitating second-line uterotonics with different receptor mechanisms (e.g., methylergonovine, carboprost tromethamine, tranexamic acid).

Uterine Tachysystole Definition

Uterine Tachysystole is defined by NICHD, ACOG, and SMFM as more than 5 contractions in 10 minutes, averaged over a 30-minute window . Tachysystole is qualified by the presence or absence of associated fetal heart rate decelerations and applies to both spontaneous and stimulated labor.

Step-by-Step Emergency Tachysystole Management Protocol

Clinical Presentation Step-by-Step Emergency Action Protocol

Tachysystole with Category I FHR Tracing (Normal baseline, moderate variability, no late/variable decelerations) 1. Lateral Maternal Repositioning: Turn patient to left or right lateral decubitus position to maximize uteroplacental perfusion.; 2. IV Hydration: Administer an IV fluid bolus of 500 mL Lactated Ringer's.; 3. Decrease Oxytocin: Reduce the oxytocin infusion rate by at least 50%.; 4. Discontinue Oxytocin: If tachysystole does not resolve within 10 to 15 minutes, stop the oxytocin infusion completely.

Tachysystole with Category II or III FHR Tracing (Recurrent late decelerations, prolonged deceleration, minimal/absent variability, or bradycardia) 1. IMMEDIATELY STOP OXYTOCIN: Turn off the oxytocin infusion immediately. Do not merely reduce the rate.; 2. Maternal Repositioning: Immediately place patient in full lateral decubitus or semi-Fowler's position.; 3. IV Fluid Bolus: Rapidly infuse 500 to 1,000 mL Lactated Ringer's wide open.; 4. Supplemental Oxygen: Administer O2 at 10 L/min via non-rebreather mask if maternal hypoxemia is present or as transient intrauterine resuscitation.; 5. Emergency Tocolysis: If fetal decelerations persist or tachysystole does not abate within 2 to 3 minutes, administer TERBUTALINE 0.25 mg SUBCUTANEOUSLY .; 6. Anesthesia & OR Alert: If FHR fails to recover within 5 to 10 minutes following tocolysis, activate emergency cesarean delivery protocol.

4. Maternal Fetal Triage Index (MFTI): 5-Level Obstetric Triage Architecture

The Maternal Fetal Triage Index (MFTI) , developed and validated by the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN), is the standardized 5-level obstetric acuity triage system designed to prioritize care and mitigate maternal-fetal morbidity. +---------------------------------------------------------------------------------------------------+

  • | AWHONN MATERNAL FETAL TRIAGE INDEX (MFTI) |
  • | |
  • | PRIORITY 1: STAT / CRITICAL (Immediate Bedside Evaluation by Provider) |
  • | • Life-threatening or unstable maternal or fetal condition. |
  • | • Clinical Triggers: Umbilical cord prolapse; sustained fetal bradycardia (<110 bpm); massive |
  • | vaginal bleeding with hemodynamic instability; active eclamptic seizure; severe respiratory |
  • | distress (SpO2 <90%, RR >35); unresponsiveness or coma; imminent precipitous delivery. |
  • | |
  • | PRIORITY 2: URGENT (Evaluation Within 15 Minutes) |
  • | • High-risk presentation with potential for rapid maternal-fetal deterioration. |
  • | • Clinical Triggers: Severe-range blood pressure (SBP >=160 or DBP >=110 mmHg); acute severe |
  • | unremitting abdominal pain; vaginal bleeding greater than menses without shock; maternal fever |
  • | >=38.0°C (100.4°F) with uterine tenderness; acute decreased fetal movement; Category II FHR |
  • | tracing requiring active resuscitation; preterm labor contractions <34 weeks with cervical |
  • | change; acute severe visual disturbances or intractable headache with hypertension. |
  • | |
  • | PRIORITY 3: PROMPT (Evaluation Within 30 Minutes) |
  • | • Stable presentation requiring targeted assessment and intervention. |
  • | • Clinical Triggers: Active labor at term (>=37 weeks) with Category I FHR; suspected spontaneous|
  • | rupture of membranes (SROM) without active labor or fever; mild-range hypertension |
  • | (SBP 140–159 or DBP 90–109 mmHg) without severe features; uncomplicated preterm contractions |
  • | without cervical change. |
  • | |
  • | PRIORITY 4: NON-URGENT (Evaluation Within 60 Minutes) |
  • | • Low-risk, stable maternal-fetal condition. |
  • | • Clinical Triggers: Early latent labor (<3 cm dilation) at term with Category I tracing; mild |
  • | dysuria or UTI symptoms without fever or flank pain; scheduled outpatient testing (e.g., NST, |
  • | BPP); mild nausea/vomiting without dehydration. |
  • | |
  • | PRIORITY 5: ROUTINE / REQUESTING SERVICE (Evaluation Within 120 Minutes) |
  • | • Non-acute administrative or elective encounter. |
  • | • Clinical Triggers: Prescription refill; routine Rhophylac (anti-D) injection; routine suture |
  • | removal; paperwork or disability documentation requests. |
  • +---------------------------------------------------------------------------------------------------+

Loading diagram... Intrapartum Tachysystole & Fetal Resuscitation Algorithm